Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 33c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Medicis Pharmaceutical Corp. (NASDAQ: MRX) | Delayed: 69.96 +1.42 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.54 | 52 Week High | $44.00 | |||
| Open | $68.23 | 52 Week Low | $30.30 | |||
| Day High | $70.40 | P/E | 101.39 | |||
| Day Low | $67.50 | EPS | $0.69 | |||
| Volume | 460,452 | |||||
